Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01876784
Title Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

thyroid gland cancer

Therapies

Vandetanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.